long-acting opioids
FDA to Widen Opioid REMS to IR Formulations
The FDA will broaden the existing opioid REMS, which currently only covers extended-release, long-acting ...
SEPTEMBER 29, 2017
FDA Adds Immediate-Release Opioids to REMS
The FDA is planning to add immediate-release opioids to its existing opioid REMS program, which since its inception ...
JULY 12, 2017
Risk for Death Increases With Prescription Long-Acting Opioids Compared to Alternative Medications
Prescribing long-acting opioids for moderate to severe chronic noncancer pain is linked to higher rates of death ...
SEPTEMBER 15, 2016
FDA Committee Votes To Modify REMS for Painkillers
The FDA's advisory committees voted to modify the REMS for ER/LA opioids. The vote was 30 to 0 for modifying the ...
MAY 10, 2016
Load more